Dr. Ravi Prakash Singh, MD, MPH Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1830 Heritage Park Plz, Murfreesboro, TN 37129 Phone: 615-895-8104 Fax: 615-895-7903 |
Jessica C Samples, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3400 Lebanon Rd, V.a. Medical Center; Alvin C York Campus, Murfreesboro, TN 37129 Phone: 615-867-6000 |
Jennifer Smith, Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1700 Medical Center Pkwy, Murfreesboro, TN 37129 Phone: 615-936-1567 |
Stephen Wesley Clark, MD Psychiatry & Neurology - Neuromuscular Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Highland Ter Ste D, Murfreesboro, TN 37130 Phone: 615-802-5900 |
News Archive
In the first study to make head-to-head comparisons between tenofovir gel and oral tenofovir - two promising approaches for preventing HIV in women - researchers found that daily use of the vaginal gel achieved a more than 100-times higher concentration of active drug in vaginal tissue than did the oral tablet, while, compared to the gel, the tablet used daily was associated with a 20-times higher active drug concentration in blood.
A team of researchers at The New York Stem Cell Foundation Research Institute led by Scott Noggle, PhD, Director of the NYSCF Laboratory and the NYSCF - Charles Evans Senior Research Fellow for Alzheimer's Disease, and Michael W. Nestor, PhD, a NYSCF Postdoctoral Research Fellow, has developed a technique to produce three-dimensional cultures of induced pluripotent stem cells called embryoid bodies, amenable to live cell imaging and to electrical activity measurement.
On the heels of dismaying reports that a promising antitumor drug could, in theory, shorten patients' long-term survival, comes a promising study by a Japanese team of researchers that suggests a potentially better option.
British researchers from Brunel University have made an astonishing discovery that could change our understanding of attention deficit, impulsivity and hyperactivity disorder (ADHD).
The regulation, five years in the making, means insurers won't be able to charge higher co-payments or deductibles for mental health services than they charge for treating physical ailments. Here's a sampling of this afternoon's news coverage of the final rule.
› Verified 2 days ago